Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

Altered signature of apoptotic endothelial cell-derived microvesicles predicts chronic heart failure phenotypes.

Berezin AE, Kremzer AA, Samura TA, Berezina TA.

Biomark Med. 2019 Jun;13(9):737-750. doi: 10.2217/bmm-2018-0449. Epub 2019 Jun 3.

PMID:
31157550
2.

An association of serum vistafin level and number of circulating endothelial progenitor cells in type 2 diabetes mellitus patients.

Berezin AE, Samura TA, Kremzer AA, Berezina TA, Martovitskaya YV, Gromenko EA.

Diabetes Metab Syndr. 2016 Oct - Dec;10(4):205-212. doi: 10.1016/j.dsx.2016.06.008. Epub 2016 Jun 8.

PMID:
27377688
3.

Data regarding association between serum osteoprotegerin level, numerous of circulating endothelial-derived and mononuclear-derived progenitor cells in patients with metabolic syndrome.

Berezin AE, Kremzer AA, Berezina TA, Martovitskaya YV, Gronenko EA.

Data Brief. 2016 Jun 29;8:717-22. doi: 10.1016/j.dib.2016.06.015. eCollection 2016 Sep.

4.

The pattern of circulating microparticles in patients with diabetes mellitus with asymptomatic atherosclerosis.

Berezin AE, Kremzer AA, Berezina TA, Martovitskaya YV.

Acta Clin Belg. 2016 Feb;71(1):38-45. doi: 10.1080/17843286.2015.1110894. Epub 2016 Feb 3.

PMID:
27075791
5.

Predictive value of circulating osteonectin in patients with ischemic symptomatic chronic heart failure.

Berezin AE, Kremzer AA.

Biomed J. 2015 Dec;38(6):523-30. doi: 10.1016/j.bj.2015.08.002. Epub 2016 Feb 19.

6.

Pattern of endothelial progenitor cells and apoptotic endothelial cell-derived microparticles in chronic heart failure patients with preserved and reduced left ventricular ejection fraction.

Berezin AE, Kremzer AA, Martovitskaya YV, Berezina TA, Gromenko EA.

EBioMedicine. 2016 Jan 20;4:86-94. doi: 10.1016/j.ebiom.2016.01.018. eCollection 2016 Feb.

7.

The utility of biomarker risk prediction score in patients with chronic heart failure.

Berezin AE, Kremzer AA, Martovitskaya YV, Samura TA, Berezina TA, Zulli A, Klimas J, Kruzliak P.

Int J Clin Exp Med. 2015 Oct 15;8(10):18255-64. eCollection 2015.

8.
9.

The predictive role of circulating microparticles in patients with chronic heart failure.

Berezin AE, Kremzer AA, Martovitskaya YV, Samura TA, Berezina TA.

BBA Clin. 2014 Dec 5;3:18-24. doi: 10.1016/j.bbacli.2014.11.006. eCollection 2015 Jun.

10.

Circulating endothelial-derived apoptotic microparticles and insulin resistance in non-diabetic patients with chronic heart failure.

Berezin AE, Kremzer AA, Cammarota G, Zulli A, Petrovic D, Martell-Claros N, Sabo J, Kruzliak P.

Clin Chem Lab Med. 2016 Jul 1;54(7):1259-67. doi: 10.1515/cclm-2015-0605.

PMID:
26656612
11.

The Association of Subclinical Hypothyroidism and Pattern of Circulating Endothelial-Derived Microparticles Among Chronic Heart Failure Patients.

Berezin AE, Kremzer AA, Martovitskaya YV, Samura TA, Berezina TA.

Res Cardiovasc Med. 2015 Sep 14;4(4):e29094. doi: 10.5812/cardiovascmed.29094. eCollection 2015 Nov.

12.

Circulating thrombospondine-2 in patients with moderate-to-severe chronic heart failure due to coronary artery disease.

Berezin AE, Kremzer AA, Samura TA.

J Biomed Res. 2015 Mar 2;30. doi: 10.7555/JBR.29.20140025. [Epub ahead of print]

13.

Pattern of circulating endothelial-derived microparticles among chronic heart failure patients with dysmetabolic comorbidities: The impact of subclinical hypothyroidism.

Berezin AE, Kremzer AA, Martovitskaya YV, Samura TA, Berezina TA.

Diabetes Metab Syndr. 2016 Jan-Mar;10(1):29-36. doi: 10.1016/j.dsx.2015.08.001. Epub 2015 Aug 21.

PMID:
26319410
14.

Impaired phenotype of circulating endothelial microparticles in chronic heart failure patients: Relevance to body mass index.

Berezin AE, Kremzer AA.

Diabetes Metab Syndr. 2015 Oct-Dec;9(4):230-6. doi: 10.1016/j.dsx.2015.04.003. Epub 2015 Apr 24.

PMID:
26044504
15.

The utility of biomarker risk prediction score in patients with chronic heart failure.

Berezin AE, Kremzer AA, Martovitskaya YV, Berezina TA, Samura TA.

Clin Hypertens. 2016 Mar 11;22:3. doi: 10.1186/s40885-016-0041-1. eCollection 2015.

16.

The effect of angiotensin-2 receptor blocker valsartan on circulating level of endothelial progenitor cells in diabetic patients with asymptomatic coronary artery disease.

Berezin AE, Kremzer AA, Martovitskaya YV, Samura TA.

Diabetes Metab Syndr. 2015 Oct-Dec;9(4):305-9. doi: 10.1016/j.dsx.2014.04.006. Epub 2014 May 19.

PMID:
25470647
17.

Serum uric Acid predicts declining of circulating proangiogenic mononuclear progenitor cells in chronic heart failure patients.

Berezin AE, Kremzer AA, Samura TA, Berezina TA, Martovitskaya YV.

J Cardiovasc Thorac Res. 2014;6(3):153-62. doi: 10.15171/jcvtr.2014.004. Epub 2014 Sep 30.

18.
19.

Predictive value of apoptotic microparticles to mononuclear progenitor cells ratio in advanced chronic heart failure patients.

Berezin AE, Kremzer AA, Samura TA, Martovitskaya YV, Malinovskiy YV, Oleshko SV, Berezina TA.

J Cardiol. 2015 May;65(5):403-11. doi: 10.1016/j.jjcc.2014.06.014. Epub 2014 Aug 7.

20.

Relationship between circulating endothelial progenitor cells and insulin resistance in non-diabetic patients with ischemic chronic heart failure.

Berezin AE, Kremzer AA.

Diabetes Metab Syndr. 2014 Jul-Sep;8(3):138-44. doi: 10.1016/j.dsx.2014.07.001. Epub 2014 Jul 28.

PMID:
25082501

Supplemental Content

Loading ...
Support Center